# FDA Inspection 1260223 - CSL Plasma Inc. - January 30, 2025

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/9387a42b-0c0d-4d3d-957e-cb3150f46929
Source feed: FDA_Inspections

> FDA Inspection 1260223 for CSL Plasma Inc. on January 30, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260223
- Company Name: CSL Plasma Inc.
- Inspection Date: 2025-01-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1260223 - 2025-01-30](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/b1a05221-87cd-43b6-9191-1fd96034e120)
- [FDA Inspection 1084493 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/e75005f1-29e2-401d-a5de-f8f55faff094)

Company: https://www.keypedia.com/companies/csl-plasma-inc/d6773af3-20fe-4a88-bb53-39e568fae77b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d